GET THE APP

..

Journal of Integrative Oncology

ISSN: 2329-6771

Open Access

Editor-in-Chief

Homer S Black

Homer S Black

Editor-in-Chief
Professor, Department of Dermatology
Baylor College of Medicine, USA

Biography

Dr. Black earned a Ph.D. in biochemistry from Louisiana State University in 1964. He earned a B.Sc. in animal science from Texas A&M University in 1956. He also holds a M.Ed. from Sam Houston State University; and a M.S.Admin. (business/health science management) from the University of Houston. He was a Senior Fulbright Scholar at the Photobiology Centre, University of Dundee, Scotland. Dr. Black has been a member of a number of scientific societies including the Sigma Xi, American Association of Cancer Research, American Oil Chemists’ Society, European Society for Photobiology, Photomedicine Society, and the American Society for Photobiology. He served as Treasurer in the latter. Dr. Black is also a member of the Institute of Professional Managers and was Chairman of the Board of Regents for the Academy of Administrative Managers. His research interests have focused upon the chemopreventive or pro-carcinogenic effects of antioxidants and dietary fat in UV-carcinogenesis.

Research Interest

Pro-carcinogenic effects of antioxidants and dietary fat in UV-carcinogenesis

Xiong-Zhi Wu

Xiong-Zhi Wu

Editor-in-Chief
Associate Professor
Tianjin Medical University, China

Biography

Dr. Xiong-Zhi Wu obtained his Ph.D. degree in 2005 at Medical School of West China, Sichuan University. Dr. Wu worked as associate Prof. of Treatment and the advisor of postgraduate in Tianjin Medical University Cancer Institute and Hospital. Dr. Wu is the vice director of integrative oncology department. Dr. Wu was award the title “creative talented Scholar” by Tianjin government and the title “outstanding talented Scholar in new century” by Tianjin Medical University, and Cancer Institute and Hospital. He is the commissioner of Committee of Rehabilitation and Palliative care. China, vice director of Committee of Rehabilitation and Palliative care. Tianjin, China, and the editor of international journals, such as Research Journal of Biological Sciences and International Journal of Molecular Medicine and Advance Sciences. He is the reviewer of manuscripts for many international Journals, such as European Surgical Research, Lancet infectious diseases, International Journal of Pharmaceutics, Histology and Histolopathology, Acta Pharmacologica Sinica. Dr. Wu published more that 50 papers and two books, and 12 papers were published in international journals and were index by SCI.

Research Interest

Integrative Oncology.

Juel Chowdhury

Juel Chowdhury

Editor-in-Chief
2016 Congress-Chicago, Director at ISOBM - International Society of Oncology and Biomarkers
Gulf Medical University, UAE

Biography

Juel Chowdhury began his professional education at the Gulf Medical University, UAE where he received his first profession degree in medicine (Doctor of Medicine). Since then, his works have led him to associate with Nobel laureate Dr. Ferid Murad and many well-known scientists such as Dr. Robert Winn Director of UI health Chicago. He is the founder and president of Oncomarks.org an online professional network with an open access journal for the oncologists. His innovative iGenX lab is a gene research lab based on data-mining and data analysis of the various gene-chip experiments. Reviewer of well known journals like Tumor Biology and JCMT. Editorial Board member of JUMD, and many professional societies like ASCO and ISOBM. He was the director of ISOBM (International society of oncology and biomarkers) 2016 congress held in Chicago and also the member of Organizing Committee for the upcoming ISOBM 2017 congress which will be hosted in Brazil. He is an expert in Botulinum Toxin and Dermal Fillers, facial reconstruction and hair transplant procedures from Ohio,USA and Poland. He also contributed as an Organizing committee of 14th and upcoming 15th Transitional medicine and oncologist meet, San Francisco, CA.

Research Interest

Targeted Cancer Therapies & Stem Cells, Hot Topics in Cancer Research, Mechanisms and Development of New Cancer Agents

arrow_upward arrow_upward